226 related articles for article (PubMed ID: 14503949)
1. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.
Contasta I; Berghella AM; Pellegrini P; Adorno D
Cancer Biother Radiopharm; 2003 Aug; 18(4):549-57. PubMed ID: 14503949
[TBL] [Abstract][Full Text] [Related]
2. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules.
Contasta I; Pellegrini P; Berghella AM; Adorno D
Cancer Biother Radiopharm; 2001 Feb; 16(1):63-71. PubMed ID: 11279799
[TBL] [Abstract][Full Text] [Related]
4. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
[TBL] [Abstract][Full Text] [Related]
5. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
6. Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network.
Contasta I; Berghella AM; Pellegrini P; Del Beato T; Casciani CA; Adorno D
Cancer Biother Radiopharm; 1999 Dec; 14(6):465-75. PubMed ID: 10850333
[TBL] [Abstract][Full Text] [Related]
7. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
[TBL] [Abstract][Full Text] [Related]
8. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides.
Schönermarck U; Csernok E; Trabandt A; Hansen H; Gross WL
Clin Exp Rheumatol; 2000; 18(4):457-63. PubMed ID: 10949720
[TBL] [Abstract][Full Text] [Related]
9. Th1 and Th2 cytokine modulation by IL-10/IL-12 imbalance in autoimmune haemolytic anaemia (AIHA).
Fagiolo E; Toriani-Terenzi C
Autoimmunity; 2002 Feb; 35(1):39-44. PubMed ID: 11908705
[TBL] [Abstract][Full Text] [Related]
10. The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments.
Pellegrini P; Contasta I; Berghella AM; Del Beato T; Casciani CU; Adorno D
Cancer Biother Radiopharm; 2000 Jun; 15(3):267-78. PubMed ID: 10941534
[TBL] [Abstract][Full Text] [Related]
11. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern.
Raziuddin S; al-Dalaan A; Bahabri S; Siraj AK; al-Sedairy S
J Rheumatol; 1998 Feb; 25(2):329-33. PubMed ID: 9489829
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors.
Inagaki A; Ishida T; Ishii T; Komatsu H; Iida S; Ding J; Yonekura K; Takeuchi S; Takatsuka Y; Utsunomiya A; Ueda R
Int J Cancer; 2006 Jun; 118(12):3054-61. PubMed ID: 16425276
[TBL] [Abstract][Full Text] [Related]
13. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
14. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis.
Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK
J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879
[TBL] [Abstract][Full Text] [Related]
15. A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.
Price P; Keane NM; Lee S; Lim AF; McKinnon EJ; French MA
Immunology; 2006 Sep; 119(1):74-82. PubMed ID: 16792698
[TBL] [Abstract][Full Text] [Related]
16. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA).
Ruschpler P; Stiehl P
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):285-93. PubMed ID: 12030433
[TBL] [Abstract][Full Text] [Related]
17. Association of CD30 transcripts with Th1 responses and proinflammatory cytokines in patients with end-stage renal disease.
Velásquez SY; Opelz G; Rojas M; Süsal C; Alvarez CM
Hum Immunol; 2016 May; 77(5):403-10. PubMed ID: 26970513
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
19. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
[TBL] [Abstract][Full Text] [Related]
20. Changes in the T-helper cell 1/T-helper cell 2 balance of peripheral T-helper cells after autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Mukai M; Bohgaki T; Kondo M; Notoya A; Kohno M
Ann Hematol; 2001 Dec; 80(12):715-21. PubMed ID: 11797111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
